Current Report Filing (8-k)
March 27 2018 - 9:45AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
March 27, 2018
InspireMD,
Inc.
(Exact name of registrant as specified in its charter)
Delaware
|
|
001-35731
|
|
26-2123838
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
4 Menorat Hamaor St.
Tel Aviv, Israel
|
|
6744832
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including area
code: (888) 776-6804
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is
an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of
the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
On March 27, 2018, InspireMD,
Inc. announced that it has received regulatory approval for the CGuard™ Embolic Prevention System and MGuard Prime™
in Peru. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is hereby incorporated
by reference herein.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
InspireMD, Inc.
|
|
|
|
Date: March 27, 2018
|
By:
|
/s/ Craig Shore
|
|
Name:
|
Craig Shore
|
|
Title:
|
Chief Financial Officer
|
InspireMD (AMEX:NSPR)
Historical Stock Chart
From Jun 2024 to Jul 2024
InspireMD (AMEX:NSPR)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about InspireMD Inc New (American Stock Exchange): 0 recent articles
More Inspiremd, Inc. News Articles